PDF file: 441-1482_changes_in_the_AEFI_program_of_self_reporting.pdf
OPQ ID: 441-1482
Session: 441
Question number: Q-1482
Sessional paper: Q-1482
Title: changes in the AEFI program of self reporting
Short description: 
Topic: vaccines
Identified concern: 
Keywords: 
Agencies: HC, PHAC
Date asked: 2023-05-01
Date tabled: 
Submitted by: Mr. Carrie (Oshawa)
Reply by: Minister of Health
Responded by: Mr. van Koeverden
Pages: 9
Status: not processed
Alert: yellow
Questions asked: 9
Questions answered: 7
Percent responded: 78%
Referenced sources: (none extracted)
Referenced links: (none extracted)
Official link: https://www.google.com/search?q=Q-1482+ourcommons.ca
PDF URL: https://ivim.ca/foi/opq/r/441-1482_changes_in_the_AEFI_program_of_self_reporting.pdf
TXT URL: https://ivim.ca/foi/opq/r/441-1482.txt
Original filename: Q-1482 (ORDER) ABOUT changes in the AEFI program of self reporting.pdf
Local source path: C:\Users\Dmitry\Documents\CODES\OPQ-App\data-raw\OPQ\ALL OPQ TO DATE\2022\Q-1482 (ORDER) ABOUT changes in the AEFI program of self reporting.pdf
Machine extracted at: 2026-06-30 12:58:13

References / links:
(none extracted)

Machine notes:
(none)

Question text preview:
With regard to Health Canada’s website currently titled “Report a side effect to a vaccine: Consumers”: (a) why was the website changed in
December 2020 to prevent consumers from reporting vaccine injuries directly to Health Canada;
(b) why did the website change back on
February 28, 2023 to allow consumers to resume reporting vaccine injuries to Health Canada;
(c) who authorized the changes in (a) and (b);
(d) how and on what dates were (i) health care providers, (ii) the general public, (iii) provincial and territorial health ministers, (iv) provincial and territorial immunization authorities, (v) regulatory bodies, (vi) local health authorities notified of each of these changes;
(e) for each notification in (d) did it mention a legal obligation to report adverse reactions;
(f) what efforts did Health Canada take to inform vaccine recipients of their ability to report adverse reactions through the website; and (g) what were the expenditures incurred by the government promoting the efforts in (f), broken down by type of expense?